HAL (France)
open access
Comparative analysis of anticholinergic burden scales to explain iatrogenic cognitive impairment in schizophrenia: results from the multicenter FACE-SZ cohort
Aim The anticholinergic properties of medications are associated with poorer cognitive performance in schizophrenia. Numerous scales have been developed to assess anticholinergic burden and yet, there is no consensus indicating which anticholinergic burden scale is more relevant for patients with sc
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Endocannabinoid Control of Microglia Activation as a New Therapeutic Target in the Treatment of Schizophrenia#902579
- Study on Predictiors and Mechanism of Conversion to Psychosis in Individuals at Ultra-high Risk Group#849350
- Localizing at-risk and early psychosis populations along data-driven clinical, cognitive, and neuroanatomical spectra#619196
- Neurophysiological Studies in Schizophrenia and Psychiatric Disorders#854052
- An Observational Study on Atypical Antipsychotics Long-term Treatment Patients With Schizophrenia#1337612
Record · ID 1358614
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive